Neogenomics (NEO) Capital Expenditures Growth (5y) (2015 - 2026)
Neogenomics (NEO) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.16% |
| Dec 31, 2025 | -2.26% |
| Sep 30, 2025 | -11.26% |
| Jun 30, 2025 | 37.12% |
| Mar 31, 2025 | -0.90% |
| Dec 31, 2024 | -17.10% |
| Sep 30, 2024 | 8.10% |
| Jun 30, 2024 | 19.08% |
| Mar 31, 2024 | 36.58% |
| Dec 31, 2023 | -14.89% |
| Sep 30, 2023 | -88.52% |
| Jun 30, 2023 | 92.41% |
| Mar 31, 2023 | 12.21% |
| Dec 31, 2022 | -55.19% |
| Sep 30, 2022 | 27.78% |
| Jun 30, 2022 | 16.21% |
| Mar 31, 2022 | 22.27% |
| Dec 31, 2021 | 40.26% |
| Sep 30, 2021 | 51.08% |
| Jun 30, 2021 | 70.67% |